Yes No
Select Number of Employees Less than 50 50-99 100-499 500-999 1,000-4,999 5,000-9,999 Greater than 10,000
Yes, please auto-fill my contact information for other publication qualification forms.
Executive Managment Group Project Leader Research/Development Graduate Student/Researcher Principal Investigator Sales & Marketing Lab Director Business Development Research Scientist Finance, Investment Lab Technician Student Postdoc Scientist Other
Emerging & Mid-Tier Biotech/Pharma Diagnostic & Device Large Pharma Academic Clinical/Contract Research Organization (CRO) Gov't, Non-Profit Service/Supply/Manufacturing Other
Request Your Free Research Report to see how companies are using corporate cards and other strategies to control expenses. For the sixth consecutive year, American Express has teamed up with CFO Research Services to identify how finance executives manage spending programs to yield sustained business results. This year's research, Getting the Most for Every Dollar, is a guide for CFOs interested in gaining insight on how other Middle Market companies can strike the appropriate balance in achieving price, service and quality to manage indirect expenses. Note: Offer Valid in the United States Only.
Position/Role: (select only one) CEO Travel Manager CFO VP Finance Controller Other Purchasing Manager Company annual revenue: (select only one) Under $2 Million $10 Million - $250 Million $2 Million - $4 Million $250 Million - $2 Billion $4 Million - $6 Million Over $2 Billion $6 Million - $10 Million Are you involved in making decisions about your company's financial management processes? Yes No Does your company use a corporate card program? Yes No If so, does your company use the American Express® Corporate Card Program? Yes No
CEO Travel Manager CFO VP Finance Controller Other Purchasing Manager
Under $2 Million $10 Million - $250 Million $2 Million - $4 Million $250 Million - $2 Billion $4 Million - $6 Million Over $2 Billion $6 Million - $10 Million
Sign up for the PharmaWeek Newsletter Today and receive breaking R&D news and business insights for biopharmaceutical company managers- a top-line look at the pharmaceutical world and surrounding arenas, and exclusive analysis on major trends, key strategies, general business insights, and career resources. Note: Offer Valid in the United States & Canada Only.
What category best describes your JOB FUNCTION? (select only one) Select your JOB FUNCTION Scientific/R & D Management Clinical Trials Management Information Technology/Information System Management Organizational/Executive Management Regulatory/Government Affairs Academic Head/Professor/Faculty Technology/Business/Legal Consultant Other What is your primary BUSINESS ACTIVITY at this business location? (select only one) Select your BUSINESS ACTIVITY Biopharma / Chemicals Biotech / Bioinformatics Academia / Government Clinical Trial Research / CRO Pharmaceutical Hospital Lab / Healthcare Other You may receive emails from CHI regarding your subscription. If you do not want to receive this, please check no. Yes No You may also receive email from CHI partners whose products match your interests. If you do not want this, please check no. Yes No
Select your JOB FUNCTION Scientific/R & D Management Clinical Trials Management Information Technology/Information System Management Organizational/Executive Management Regulatory/Government Affairs Academic Head/Professor/Faculty Technology/Business/Legal Consultant Other
Select your BUSINESS ACTIVITY Biopharma / Chemicals Biotech / Bioinformatics Academia / Government Clinical Trial Research / CRO Pharmaceutical Hospital Lab / Healthcare Other
Request your free On-Demand Webcast - Going Green: What's Good for the Environment is Good for Business. View this informative webcast featuring Gartner "Green IT / high performance workplace" analyst Mark Gilbert and Xerox VP of Environment, Health and Safety, Patricia Calkins. Discover how you can: Adopt policies that reduce waste, energy use, and greenhouse gasses while increasing efficiencies / ROI.Create an "early win" using Enterprise Content Management (ECM) solutions that will save your organization paper, energy, time, money, and waste. Employ some of the steps that Xerox and its customers have taken to dramatically reduce their carbon footprint and cut costs. Note: Offer Valid in the United States and Canada Only.
What is the number of employees in your entire organization? (select only one) 1-99 1,000-4,999 100-999 5,000+ Do you currently have a budget defined for your project? Yes No If Yes, are you the budget owner? Yes No How many months have you been researching potential solutions? (select only one) 0-3 months 6-9 months 3-6 months 9-12 months What is your timeframe for making a purchasing decision? (select only one) 90 days or less 181 days to 270 days 91 to 180 days 271 days to 360 days
1-99 1,000-4,999 100-999 5,000+
Yes No If Yes, are you the budget owner? Yes No
0-3 months 6-9 months 3-6 months 9-12 months
90 days or less 181 days to 270 days 91 to 180 days 271 days to 360 days
4 FREE Trial ISSUES OFFER OF The Economist! Insights on the world, weekly. The Economist is a global weekly magazine written and edited for readers who share an uncommon interest in being well and broadly informed. With objective authority, clarity and wit, The Economist presents well-considered analysis of the world's business, political, scientific, technological and cultural affairs and the connections between them. Subscribe to The Economist today and you'll get 4 RISK-FREE issues as a free trial. If you wish to continue your subscription, you'll receive 20 additional issues - 24 in all for just $2.49 an issue (total of $59.76). That's 58% off the cover price. If you decide The Economist is not for you, write 'cancel' on the bill, return it and owe nothing. Note: Offer Valid in the United States Only.
Click below if you wish to receive email from: (select all that apply) The Economist The Economist and other Economist Group companies The Economist, The Economist Group and selected third parties authorized by The Economist
The Economist The Economist and other Economist Group companies The Economist, The Economist Group and selected third parties authorized by The Economist